Sjogren's Syndrome Market

Oct 07, 2020

10 likes | 21 Views

In 2017, the total prevalent cases of Sjogrenu2019s Syndrome in 7MM was 3,179,223. The prevalent cases in Spain was found to be 197,008 in 2017. The market size of Sjogrenu2019s Syndrome in 7MM in 2017 was USD 1,699.8 Million, which is expected to increase further during the forecast period 2017-2030.. The key companies involved in developing therapies for Sjogrenu2019s Syndrome include Novartis, MorphoSys, Resolve Therapeutics, GlaxoSmithKline, VIELABIO, RemeGen, Bristol Myers Squibb and many others. For more details visit: https://www.delveinsight.com/report-store/sjogrens-syndrome-market-size

DelveInsight

Download Presentation

Sjogren's Syndrome Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D